Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Kallistatin: A New Horizon in Obesity and Type 2 Diabetes Treatment
Copy link
Facebook
Email
Notes
More

Kallistatin: A New Horizon in Obesity and Type 2 Diabetes Treatment

Discovering the role of Kallistatin in enhancing metabolism post-weight loss and its potential as a novel therapeutic target.

Naveen Sankar S's avatar
Naveen Sankar S
Mar 21, 2024
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Kallistatin: A New Horizon in Obesity and Type 2 Diabetes Treatment
Copy link
Facebook
Email
Notes
More
Share
An illustration showing the concept of weight loss leading to improved health through a metaphorical image. Visualize a person standing on one side of a scale and a healthier version of themselves on the other side, with symbols of health like fruits, vegetables, and a liver glowing with vitality to represent improved metabolism and insulin sensitivity. The background should be light and hopeful, symbolizing a positive transformation and new beginnings, without including any letters or numbers.

Topline:

A groundbreaking study reveals that Kallistatin, a protein expressed after weight loss, significantly improves metabolism and offers new therapeutic possibilities for managing obesity and type 2 diabetes.

Study Details:

Obesity and type 2 diabetes are escalating health crises globally, necessitating innovative treatment strategies. Researchers f…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More